35 results on '"Kawano, Haruna"'
Search Results
2. Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
3. Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease
4. Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease
5. Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men
6. Kidney Transplantation for a Patient With Protein C Deficiency Using Activated Protein C Concentrate: A Case Report
7. Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease
8. Long-Term Effects of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Predictors of Treatment Response and Safety over 6 Years of Continuous Therapy
9. Retrospective observational study of a novel smartphone app on the management of patients with mild cognitive impairment or mild dementia
10. High prevalence of frailty in patients with lower urinary tract symptoms
11. PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
12. Clinical Practice Guidelines for tuberous sclerosis complex‐associated renal angiomyolipoma by the Japanese Urological Association: Summary of the update
13. Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease
14. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
15. Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases
16. Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
17. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD)
18. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease
19. The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial
20. Gut environment changes due to androgen deprivation therapy in patients with prostate cancer
21. Gut environment changes due to androgen deprivation therapy in patients with prostate cancer
22. Gut Environment Changes Due to Androgen Deprivation Therapy in Patients With Prostate Cancer
23. Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan
24. A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020.
25. A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondria morphology and function when heterologously expressed
26. Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease
27. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
28. Technical Evaluation: Identification of Pathogenic Mutations in PKD1 and PKD2 in Patients with Autosomal Dominant Polycystic Kidney Disease by Next-Generation Sequencing and Use of a Comprehensive New Classification System
29. 2G2-4 Study on work characteristics and effects while working in adjustable sit-stand worktable(7)
30. A potentially crucial role of the <italic>PKD1</italic> C-terminal tail in renal prognosis.
31. Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway
32. FP058THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
33. Establishment of Tsc2-deficient rat embryonic stem cells
34. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease
35. Bladder Metastasis of Extramammary Paget’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.